Cargando…

Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis

Systemic amyloidosis can be hereditary or acquired with autosomal dominant mutations in the transthyretin gene (TTR) being the most common cause of hereditary amyloidosis. ATTRm amyloidosis is a multi-system disorder with cardiovascular, peripheral and autonomic nerve involvement that can be difficu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Mahima, Rossor, Alexander M., Laura, Matilde, Reilly, Mary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598024/
https://www.ncbi.nlm.nih.gov/pubmed/30829617
http://dx.doi.org/10.3233/JND-180371
_version_ 1783430688241876992
author Kapoor, Mahima
Rossor, Alexander M.
Laura, Matilde
Reilly, Mary M.
author_facet Kapoor, Mahima
Rossor, Alexander M.
Laura, Matilde
Reilly, Mary M.
author_sort Kapoor, Mahima
collection PubMed
description Systemic amyloidosis can be hereditary or acquired with autosomal dominant mutations in the transthyretin gene (TTR) being the most common cause of hereditary amyloidosis. ATTRm amyloidosis is a multi-system disorder with cardiovascular, peripheral and autonomic nerve involvement that can be difficult to diagnose due to phenotypic heterogeneity. This review will focus on the neuropathic manifestations of ATTRm, the genotype-phenotype variability, the diagnostic approach and the recent therapeutic advances in this disabling condition.
format Online
Article
Text
id pubmed-6598024
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-65980242019-07-01 Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis Kapoor, Mahima Rossor, Alexander M. Laura, Matilde Reilly, Mary M. J Neuromuscul Dis Review Systemic amyloidosis can be hereditary or acquired with autosomal dominant mutations in the transthyretin gene (TTR) being the most common cause of hereditary amyloidosis. ATTRm amyloidosis is a multi-system disorder with cardiovascular, peripheral and autonomic nerve involvement that can be difficult to diagnose due to phenotypic heterogeneity. This review will focus on the neuropathic manifestations of ATTRm, the genotype-phenotype variability, the diagnostic approach and the recent therapeutic advances in this disabling condition. IOS Press 2019-05-21 /pmc/articles/PMC6598024/ /pubmed/30829617 http://dx.doi.org/10.3233/JND-180371 Text en © 2019 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kapoor, Mahima
Rossor, Alexander M.
Laura, Matilde
Reilly, Mary M.
Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title_full Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title_fullStr Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title_full_unstemmed Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title_short Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
title_sort clinical presentation, diagnosis and treatment of ttr amyloidosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598024/
https://www.ncbi.nlm.nih.gov/pubmed/30829617
http://dx.doi.org/10.3233/JND-180371
work_keys_str_mv AT kapoormahima clinicalpresentationdiagnosisandtreatmentofttramyloidosis
AT rossoralexanderm clinicalpresentationdiagnosisandtreatmentofttramyloidosis
AT lauramatilde clinicalpresentationdiagnosisandtreatmentofttramyloidosis
AT reillymarym clinicalpresentationdiagnosisandtreatmentofttramyloidosis